加拿大放射肿瘤科医生使用单次分割姑息放疗治疗无并发症骨转移的行为决定因素
该研究基于理论域框架(TDF)对加拿大10个省的38名放射肿瘤科医生进行半结构化访谈,分析其使用单次分割放疗(SFRT)治疗无并发症骨转移的行为决定因素。最常见促进因素为医生知晓SFRT证据和指南(100%),最常见障碍为SFRT与再治疗风险较高相关(81.6%)。
要点
- 所有受访医生均知晓SFRT证据和指南,但临床使用仍不普遍。
- SFRT便利患者是主要促进因素,而再治疗风险高是主要障碍。
- 同事使用行为和自身经验可影响SFRT的使用。
核心结论
- 利用TDF识别出影响加拿大放射肿瘤科医生使用SFRT的一系列促进和阻碍因素,可指导未来干预设计以提高SFRT使用率。
研究设计与样本
- 对来自加拿大全部10个省的38名放射肿瘤科医生进行半结构化访谈,访谈提纲和分析基于理论域框架(TDF),采用5阶段主题内容分析。
主要发现
- 最常见主题为促进因素「大多数放射肿瘤科医生知晓SFRT的证据和指南」(n=38,100%)。
- 接下来3个报告最多的主题(n=37,97.4%)分别为:医生使用SFRT可影响同事使用(分歧因素)、SFRT经验可增加其使用(促进因素)、SFRT对患者便利(促进因素)。
- 最常见障碍因素为「SFRT与再治疗风险较高相关」(n=31,81.6%)。
临床怎么用
- 可针对再治疗风险顾虑和同事影响等可干预因素设计策略,以促进SFRT在无并发症骨转移中的使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A mainstay therapy for pain relief from uncomplicated bone metastases is external beam radiation therapy. Single fraction radiation therapy (SFRT) is more convenient and cost-effective, causes fewer acute side effects, and is equivalent to multiple fraction radiation therapy for pain relief. Despite these advantages, radiation oncologists seldom prescribe SFRT. PURPOSE: To identify the behavioral determinants to Canadian radiation oncologists' use of SFRT for uncomplicated bone metastases. METHODS AND MATERIALS: Semistructured interviews were conducted with 38 radiation oncologists from all 10 Canadian provinces. The interview guide and analysis were guided by the Theoretical Domains Framework (TDF). Transcripts were analyzed using a 5-phase thematic content analysis process: coding, generation of belief statements, generation of themes within TDF domains, generation of overarching themes, and classification of themes as barriers or facilitators to SFRT use, or as divergent (a barrier or facilitator depending on the participant). RESULTS: Thirteen overarching themes were identified of which 2 were barriers, 7 were facilitators, and 4 were divergent. The most commonly identified theme was the facilitator "most radiation oncologists are aware of evidence and guidelines on the use SFRT" (n = 38, 100%). The 3 next most reported themes (n = 37, 97.4% ) were (1) "radiation oncologists' use of SFRT can influence their colleagues" use of it (divergent), (2) experience with SFRT can increase its use (facilitator), and (3) SFRT is convenient for patients (facilitator). The most commonly identified barrier (n = 31, 81.6%) was "SFRT is associated with a higher risk of retreatment." CONCLUSIONS: Our use of the TDF to explore the behavioral determinants of Canadian radiation oncologists' use of SFRT for uncomplicated bone metastases identified a range of factors that are perceived to encourage and discourage its use. Our results will inform the design of future interventions to increase the use of SFRT.
引用
- Squires JE, Asad S, Varin MD, et al. Behavioral Determinants of Canadian Radiation Oncologists' Use of Single Fraction Palliative Radiation Therapy for Uncomplicated Bone Metastases. Int J Radiat Oncol Biol Phys. 2020. PMID: 32966890. doi:10.1016/j.ijrobp.2020.09.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。